Literature DB >> 32342269

Identification of gene co-expression modules and hub genes associated with the invasiveness of pituitary adenoma.

Yuancheng Zhou1,2, Xiaorui Fu1,3, Zhicheng Zheng1,4, Yu Ren1,2, Zijian Zheng1,2, Bohan Zhang1,2, Min Yuan5, Jian Duan1, Meihua Li1, Tao Hong1, Guohui Lu6, Dongwei Zhou7.   

Abstract

In pituitary adenoma (PA), invasiveness is the main cause of recurrence and poor prognosis. Thus, identifying specific biomarkers for diagnosis and effective treatment of invasive PAs is of great clinical significance. In this study, from the Gene Expression Omnibus database, we obtained and combined several microarrays of PA by the "sva" R package. Weighted gene co-expression network analysis was performed to construct a scale-free topology model and analyze the relationships between the modules and clinical traits. Our analysis results indicated that three key modules (dark turquoise, saddle brown, and steel blue) were associated with the invasiveness of PA. Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis and Gene Ontology analysis were performed for the functional annotation of the key modules. In addition, the hub genes in the three modules were identified and screened by differential expression analysis between normal samples and PA samples. Three upregulated differentially expressed genes (DGAT2, PIGZ, and DHRS2) were identified. The Fisher's exact test and receiver operating characteristic curve were used to validate the capability of these genes to distinguish invasive traits, and transcription factor interaction networks were used to further explore the underlying mechanisms of the three genes. Moreover, a lower expression level of DGAT2 in invasive PA tissue than in noninvasive PA tissue was validated by quantitative reverse transcription-polymerase chain reaction. In general, this study contributes to potential molecular biomarkers of invasive PAs and provides a broader perspective for diagnosis and new therapeutic targets for the invasive PAs.

Entities:  

Keywords:  Hub genes; Invasiveness; Pituitary adenoma; Weighted gene co-expression network analysis

Mesh:

Substances:

Year:  2020        PMID: 32342269     DOI: 10.1007/s12020-020-02316-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  49 in total

1.  Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.

Authors:  Ann I McCormack; John A H Wass; Ashley B Grossman
Journal:  Eur J Clin Invest       Date:  2011-04-18       Impact factor: 4.686

2.  Pathology of invasive pituitary tumors with special reference to functional classification.

Authors:  B W Scheithauer; K T Kovacs; E R Laws; R V Randall
Journal:  J Neurosurg       Date:  1986-12       Impact factor: 5.115

3.  Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.

Authors:  Sabrina Chiloiro; Francesco Doglietto; Barbara Trapasso; Donato Iacovazzo; Antonella Giampietro; Francesco Di Nardo; Chiara de Waure; Libero Lauriola; Annunziato Mangiola; Carmelo Anile; Giulio Maira; Laura De Marinis; Antonio Bianchi
Journal:  Neuroendocrinology       Date:  2015-01-29       Impact factor: 4.914

Review 4.  The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.

Authors:  M Beatriz S Lopes
Journal:  Acta Neuropathol       Date:  2017-08-18       Impact factor: 17.088

5.  Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.

Authors:  K Thapar; K Kovacs; B W Scheithauer; L Stefaneanu; E Horvath; P J Pernicone; D Murray; E R Laws
Journal:  Neurosurgery       Date:  1996-01       Impact factor: 4.654

Review 6.  Epidemiology and etiopathogenesis of pituitary adenomas.

Authors:  Elena D Aflorei; Márta Korbonits
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

7.  The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.

Authors:  Björn P Meij; Maria-Beatriz S Lopes; Dilantha B Ellegala; Tord D Alden; Edward R Laws
Journal:  J Neurosurg       Date:  2002-02       Impact factor: 5.115

Review 8.  Clinical review: Diagnosis and management of pituitary carcinomas.

Authors:  Gregory A Kaltsas; Panagiotis Nomikos; George Kontogeorgos; Michael Buchfelder; Ashley B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

Review 9.  Epidemiology of Brain Tumors.

Authors:  Jill S Barnholtz-Sloan; Quinn T Ostrom; David Cote
Journal:  Neurol Clin       Date:  2018-06-15       Impact factor: 3.806

Review 10.  Management of aggressive pituitary adenomas: current treatment strategies.

Authors:  Michael Buchfelder
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.